NewsBenzingaOrmat Technologies公布2026年第二季度业绩：完整财报电话会议记录 Ormat Technologies公布2026年第二季度业绩：完整财报电话会议记录 Benzinga 2026.10.09 11:13 (GMT+0) Open on Benzinga Other news Committee For Medicinal Products For Human Use Recommends Approval Of Indication Extension Of Johnson & Johnson's TALVEY To Treat Adults With Relapsed Or Refractory Multiple Myeloma M&T Bank Q3 2026 Earnings Call Transcript Reported October 15, 'DeepSeek offers user refunds after suffering another major outage' - SCMP Top 3 Health Care Stocks That May Fall Off A Cliff In October Keybanc Downgrades Workday to Sector Perform What's Going On With Arm Stock Friday?
Committee For Medicinal Products For Human Use Recommends Approval Of Indication Extension Of Johnson & Johnson's TALVEY To Treat Adults With Relapsed Or Refractory Multiple Myeloma
